Chemotherapy intensification for first-line treatment of poor-prognosis metastatic germ cell cancer is not yet ready for prime time

被引：0
|
作者：
Jiang, Di Maria [1 ]
Hamilton, Robert J. [2 ]
Hansen, Aaron R. [1 ]
机构：
[1] Univ Toronto, Div Med Oncol & Haematol, Princess Margaret Canc Ctr, Toronto, ON, Canada
[2] Univ Toronto, Div Urol, Dept Surg Oncol, Princess Margaret Canc Ctr, Toronto, ON, Canada
来源：
CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL | 2020年 / 14卷 / 02期
关键词：
PHASE-III; CISPLATIN; IFOSFAMIDE; PACLITAXEL; ETOPOSIDE;
D O I：
10.5489/cuaj.6407
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：48 / 49
页数：2
相关论文
共 50 条
  • [1] Early experience with chemotherapy intensification for poor- prognosis metastatic germ cell cancer and unfavorable tumor marker decline
    Batra, Anupam
    Ernst, Scott
    Potvin, Kylea
    Fernandes, Ricardo
    Power, Nicholas
    Vanhie, James
    Winquist, Eric
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2020, 14 (02): : 43 - 47
  • [2] Phase III Randomized trial of conventional-dose chemotherapy with or without high-dose chemotherapy and autologous hematopoietic stem-cell rescue as first-line treatment for patients with poor-prognosis metastatic germ cell tumors
    Motzer, Robert J.
    Nichols, Craig J.
    Margolin, Kim A.
    Bacik, Jennifer
    Richardson, Paul G.
    Vogelzang, Nicholas J.
    Bajorin, Dean F.
    Lara, Primo N., Jr.
    Einhorn, Lawrence
    Mazumdar, Madhu
    Bosl, George J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (03) : 247 - 256
  • [3] Management of poor-prognosis or relapsed germ-cell cancer
    Daugaard, Gedske
    BJU INTERNATIONAL, 2009, 104 (9B) : 1392 - 1397
  • [4] First-Line Chemotherapy of Disseminated Germ Cell Tumors
    Nichols, Craig
    Kollmannsberger, Christian
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2011, 25 (03) : 543 - +
  • [5] Successful treatment of disseminated extragonadal germ cell cancer with intensive conventional chemotherapy after first-line high-dose chemotherapy
    Yuasa T.
    Yoshida T.
    Wakabayashi Y.
    Kataoka A.
    Narita M.
    Yoshiki T.
    Okada Y.
    International Journal of Clinical Oncology, 2006, 11 (1) : 60 - 63
  • [6] High-dose sequential chemotherapy (HDS) versus PEB chemotherapy as first-line treatment of patients with poor prognosis germ-cell tumors: mature results of an Italian randomized phase II study
    Necchi, A.
    Mariani, L.
    Di Nicola, M.
    Lo Vullo, S.
    Nicolai, N.
    Giannatempo, P.
    Raggi, D.
    Fare, E.
    Magni, M.
    Piva, L.
    Matteucci, P.
    Catanzaro, M.
    Biasoni, D.
    Torelli, T.
    Stagni, S.
    Bengala, C.
    Barone, C.
    Schiavetto, I.
    Siena, S.
    Carlo-Stella, C.
    Pizzocaro, G.
    Salvioni, R.
    Gianni, A. M.
    ANNALS OF ONCOLOGY, 2015, 26 (01) : 167 - 172
  • [7] First-Line Chemotherapy for Metastatic Breast Cancer
    Telli, Melinda L.
    Carlson, Robert W.
    CLINICAL BREAST CANCER, 2009, 9 : S66 - S72
  • [8] Low Survival in Poor Prognosis Metastatic Germ Cell Cancer in Belarus
    Rolevich, Alexander, I
    Borodin, Denis M.
    Rabcheuski, Anton N.
    Ivanitskaya, Tatsiana A.
    Semenov, Sviataslau A.
    Artsiushkevich, Liudmila, V
    Sukalinskaya, Alena, V
    Zhavrid, Edvard A.
    Krasny, Sergei A.
    Konoplya, Natalia E.
    Polyakov, Sergey L.
    JCO GLOBAL ONCOLOGY, 2021, 7 : 63 - 71
  • [9] Dose-dense chemotherapy for untreated poor-prognosis and relapsed germ-cell tumours: an 18-year experience with GAMEC chemotherapy
    Shamash, Jonathan
    Mee, Matthew
    Sarker, Shah-Jalal
    Wilson, Peter
    Ansell, Wendy
    Greenwood, Michelle
    Berney, Dan
    Alifrangis, Constantine
    BJU INTERNATIONAL, 2020, 125 (06) : 843 - 852
  • [10] Intraperitoneal chemotherapy in first-line combination treatment for advanced ovarian cancer
    Massard, Christophe
    Lhomme, Catherine
    Pautier, Patricia
    BULLETIN DU CANCER, 2007, 94 (04) : 398 - 404
12345